carnitine has been researched along with Acetonemia in 33 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was performed to evaluate carnitine deficiency in a large series of epilepsy children and adolescents treated with old and new antiepileptic drugs with or without ketogenic diet." | 9.12 | Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. ( Auricchio, G; Coppola, G; Epifanio, G; Federico, RR; Pascotto, A; Resicato, G, 2006) |
| "We observed two patients who developed coma following administration of valproate in dosages of 32 to 40 mg/kg per day." | 5.28 | Valproate-induced coma with ketosis and carnitine insufficiency. ( Bohan, TP; Lin, SN; Triggs, WJ; Willmore, LJ, 1990) |
| "Clinical studies revealed an absence of ketosis on fasting (plasma beta-hydroxybutyrate less than 0." | 5.27 | Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. ( Baker, L; Coates, PM; Corkey, BE; Gonzales, EL; Hale, DE; Hall, CL; Kelley, RI; Stanley, CA; Williamson, JR; Yang, W, 1983) |
| "This study was performed to evaluate carnitine deficiency in a large series of epilepsy children and adolescents treated with old and new antiepileptic drugs with or without ketogenic diet." | 5.12 | Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. ( Auricchio, G; Coppola, G; Epifanio, G; Federico, RR; Pascotto, A; Resicato, G, 2006) |
| "Carnitine acts as a carrier of fatty acyl groups as long-chain acyl-CoA derivatives do not penetrate the mitochondrial inner membrane." | 2.55 | Disturbed bovine mitochondrial lipid metabolism: a review. ( Bruckmaier, RM; Gerber, V; Gross, JJ; Han van der Kolk, JH, 2017) |
| "In experiment 1, induction of ketosis through feed restriction on d 5 postpartum upregulated FGF21, its co-receptor KLB, and PPARA but only elicited a numerical increase in serum FGF21 concentration." | 1.42 | Alterations in Hepatic FGF21, Co-Regulated Genes, and Upstream Metabolic Genes in Response to Nutrition, Ketosis and Inflammation in Peripartal Holstein Cows. ( Akbar, H; Batistel, F; Drackley, JK; Loor, JJ, 2015) |
| "The patient was lethargic." | 1.37 | Beta-ketothiolase deficiency brought with lethargy: case report. ( Arica, SG; Arica, V; Dag, H; Gülbayzar, S; Obut, O; Onur, H, 2011) |
| "We observed two patients who developed coma following administration of valproate in dosages of 32 to 40 mg/kg per day." | 1.28 | Valproate-induced coma with ketosis and carnitine insufficiency. ( Bohan, TP; Lin, SN; Triggs, WJ; Willmore, LJ, 1990) |
| "Clinical studies revealed an absence of ketosis on fasting (plasma beta-hydroxybutyrate less than 0." | 1.27 | Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. ( Baker, L; Coates, PM; Corkey, BE; Gonzales, EL; Hale, DE; Hall, CL; Kelley, RI; Stanley, CA; Williamson, JR; Yang, W, 1983) |
| "The overall frequency of ketonuria at (re)admission was 45% together with moderately elevated or high 3-hydroxybutyrate serum concentrations." | 1.27 | Ketosis, serum carnitine and its precursor amino acids in normal and diabetic ethiopians. ( Kohnert, KD; Löster, H; Lubs, H; Peters, WH; Seim, H; Strack, E, 1987) |
| "3." | 1.27 | The effects of post-exercise glucose and alanine ingestion on plasma carnitine and ketosis in humans. ( Carlin, JI; Olson, EB; Peters, HA; Reddan, WG, 1987) |
| "Carnitine is an essential factor in long-chain fatty acid oxidation." | 1.26 | Carnitine and carnitine palmitoyltransferase in fatty acid oxidation and ketosis. ( Hoppel, CL, 1982) |
| "Thus, ketosis is viewed as the result of increased mobilization of free fatty acids from adipose tissue (site 1) to the liver (site 2), coupled with simultaneous enhancement of the liver's capacity to convert these substrates into acetoacetic and beta-hydroxybutyric acids." | 1.26 | Hormonal control of ketogenesis. Biochemical considerations. ( Foster, DW; McGarry, JD, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (39.39) | 18.7374 |
| 1990's | 6 (18.18) | 18.2507 |
| 2000's | 6 (18.18) | 29.6817 |
| 2010's | 6 (18.18) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Bleeker, JC | 1 |
| Visser, G | 1 |
| Clarke, K | 2 |
| Ferdinandusse, S | 1 |
| de Haan, FH | 1 |
| Houtkooper, RH | 1 |
| IJlst, L | 1 |
| Kok, IL | 1 |
| Langeveld, M | 1 |
| van der Pol, WL | 1 |
| de Sain-van der Velden, MGM | 1 |
| Sibeijn-Kuiper, A | 1 |
| Takken, T | 1 |
| Wanders, RJA | 1 |
| van Weeghel, M | 1 |
| Wijburg, FA | 1 |
| van der Woude, LH | 1 |
| Wüst, RCI | 1 |
| Cox, PJ | 2 |
| Jeneson, JAL | 1 |
| Xu, ZR | 1 |
| Zhu, XY | 1 |
| Lu, W | 1 |
| Sun, WH | 1 |
| Cheng, RQ | 1 |
| Ni, JW | 1 |
| Xi, L | 1 |
| Hussain, K | 1 |
| Luo, FH | 1 |
| Zhang, MY | 1 |
| Han van der Kolk, JH | 1 |
| Gross, JJ | 1 |
| Gerber, V | 1 |
| Bruckmaier, RM | 1 |
| Jeong, JK | 1 |
| Choi, IS | 1 |
| Moon, SH | 1 |
| Lee, SC | 1 |
| Kang, HG | 1 |
| Jung, YH | 1 |
| Park, SB | 1 |
| Kim, IH | 1 |
| Akbar, H | 1 |
| Batistel, F | 1 |
| Drackley, JK | 1 |
| Loor, JJ | 1 |
| Kirk, T | 1 |
| Ashmore, T | 1 |
| Willerton, K | 1 |
| Evans, R | 1 |
| Smith, A | 1 |
| Murray, AJ | 1 |
| Stubbs, B | 1 |
| West, J | 1 |
| McLure, SW | 1 |
| King, MT | 1 |
| Dodd, MS | 1 |
| Holloway, C | 1 |
| Neubauer, S | 1 |
| Drawer, S | 1 |
| Veech, RL | 1 |
| Griffin, JL | 1 |
| Arica, V | 1 |
| Arica, SG | 1 |
| Dag, H | 1 |
| Onur, H | 1 |
| Obut, O | 1 |
| Gülbayzar, S | 1 |
| Soeters, MR | 1 |
| Serlie, MJ | 1 |
| Sauerwein, HP | 1 |
| Duran, M | 1 |
| Ruiter, JP | 1 |
| Kulik, W | 1 |
| Ackermans, MT | 1 |
| Minkler, PE | 1 |
| Hoppel, CL | 3 |
| Wanders, RJ | 1 |
| Houten, SM | 1 |
| Giannessi, F | 1 |
| Pessotto, P | 1 |
| Tassoni, E | 1 |
| Chiodi, P | 1 |
| Conti, R | 1 |
| De Angelis, F | 1 |
| Dell'Uomo, N | 1 |
| Catini, R | 1 |
| Deias, R | 1 |
| Tinti, MO | 1 |
| Carminati, P | 1 |
| Arduini, A | 1 |
| Coppola, G | 1 |
| Epifanio, G | 1 |
| Auricchio, G | 1 |
| Federico, RR | 1 |
| Resicato, G | 1 |
| Pascotto, A | 1 |
| Bodamer, OA | 1 |
| Hussein, K | 1 |
| Morris, AA | 1 |
| Langhans, CD | 1 |
| Rating, D | 1 |
| Mayatepek, E | 1 |
| Leonard, JV | 1 |
| Beattie, MA | 2 |
| Winder, WW | 2 |
| Stanley, CA | 1 |
| Hale, DE | 1 |
| Coates, PM | 1 |
| Hall, CL | 1 |
| Corkey, BE | 1 |
| Yang, W | 1 |
| Kelley, RI | 1 |
| Gonzales, EL | 1 |
| Williamson, JR | 1 |
| Baker, L | 1 |
| Genuth, SM | 1 |
| Christodoulou, J | 1 |
| Hoare, J | 1 |
| Hammond, J | 1 |
| Ip, WC | 1 |
| Wilcken, B | 1 |
| Elpeleg, ON | 1 |
| Ruitenbeek, W | 1 |
| Jakobs, C | 1 |
| Barash, V | 1 |
| De Vivo, DC | 1 |
| Amir, N | 1 |
| Ballaban-Gil, K | 1 |
| Callahan, C | 1 |
| O'Dell, C | 1 |
| Pappo, M | 1 |
| Moshé, S | 1 |
| Shinnar, S | 1 |
| Sankar, R | 1 |
| Sotero de Menezes, M | 1 |
| Nowaczyk, MJ | 1 |
| Whelan, D | 1 |
| Hill, RE | 1 |
| Clarke, JT | 1 |
| Pollitt, RJ | 1 |
| Blanchard, G | 1 |
| Paragon, BM | 1 |
| Milliat, F | 1 |
| Lutton, C | 1 |
| Berry-Kravis, E | 1 |
| Booth, G | 1 |
| Sanchez, AC | 1 |
| Woodbury-Kolb, J | 1 |
| McGarry, JD | 3 |
| Foster, DW | 3 |
| Robles-Valdes, C | 2 |
| Bianchi, PB | 1 |
| Davis, AT | 1 |
| Triggs, WJ | 1 |
| Bohan, TP | 1 |
| Lin, SN | 1 |
| Willmore, LJ | 1 |
| Peters, WH | 1 |
| Seim, H | 1 |
| Löster, H | 1 |
| Strack, E | 1 |
| Lubs, H | 1 |
| Kohnert, KD | 1 |
| Carlin, JI | 1 |
| Olson, EB | 1 |
| Peters, HA | 1 |
| Reddan, WG | 1 |
| Rebouche, CJ | 1 |
| Paulson, DJ | 1 |
| Erfle, JD | 1 |
| Sauer, FD | 1 |
| Fisher, LJ | 1 |
| Huth, W | 1 |
| Dierich, C | 1 |
| von Oeynhausen, V | 1 |
| Seubert, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Acute Nutritional Ketosis in VLCAD Deficiency: Testing the Metabolic Base for Therapeutic Use[NCT03531554] | 5 participants (Actual) | Interventional | 2016-04-01 | Completed | |||
| Acute Nutritional Ketosis and Exercise in Glycogen Storage Disease Type IIIa[NCT03011203] | 6 participants (Actual) | Interventional | 2017-02-10 | Completed | |||
| A Single-centre, Randomised, Single-blinded Crossover Study Evaluating the Metabolic Effects of a Ketone Ester Food Supplement in People With Type 1 Diabetes[NCT04487678] | 0 participants (Actual) | Interventional | 2023-08-31 | Withdrawn (stopped due to Prioritization of other projects) | |||
| Efficacy of Exogenous Ketone Esters for Children With Refractory Convulsive Status Epileptics[NCT05674552] | Phase 2/Phase 3 | 50 participants (Anticipated) | Interventional | 2023-01-10 | Recruiting | ||
| Efficacy of Ketone Esters for Children With Drug Resistant Epilepsy[NCT05670847] | Phase 2/Phase 3 | 60 participants (Anticipated) | Interventional | 2023-01-10 | Recruiting | ||
| Assessment of Fuel Utilization and Circadian Rhythms in Overweight, Older Adults Following Time Restricted Eating - Phase 2 (FAR Phase 2)[NCT05482711] | 15 participants (Anticipated) | Interventional | 2023-01-10 | Recruiting | |||
| A Pilot Study Evaluating a Ketogenic Diet Concomitant to Nivolumab and Ipilimumab in Patients With Metastatic Renal Cell Carcinoma[NCT05119010] | 60 participants (Anticipated) | Interventional | 2023-03-24 | Recruiting | |||
| Correlation Between Carnitine Deficiency and Hypoglycemic Events in Type I Diabetes; Effects of Carnitine Supplementation on Hypoglycemic Events in Type I Diabetes[NCT00351234] | 200 participants (Actual) | Observational | 2004-10-31 | Completed | |||
| In Vivo Study of Safety, Tolerability and Dosing Effect on SMN mRNA and Protein Levels of Valproic Acid in Patients With Spinal Muscular Atrophy[NCT00374075] | Phase 1 | 42 participants | Interventional | 2003-09-30 | Completed | ||
| Phase I/II Trial of Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy Type I (CARNI-VAL Type I)[NCT00661453] | Phase 1/Phase 2 | 40 participants (Actual) | Interventional | 2008-04-30 | Completed | ||
| Multi-center Phase II Trial of Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy (SMA CARNI-VAL Trial)[NCT00227266] | Phase 2 | 94 participants (Actual) | Interventional | 2005-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00661453)
Timeframe: -2 weeks, time 0, 3 months, 6 months
| Intervention | g (Mean) | |||||
|---|---|---|---|---|---|---|
| Lean Mass Baseline | Lean Mass 3 months | Lean Mass 6 months | Fat Mass Baseline | Fat Mass 3 months | Fat Mass 6 months | |
| SMA Type 1 | 4317.15 | 4993.92 | 5133.83 | 3011.37 | 3618.25 | 4316.08 |
The maximum Compound Motor Action Potential (CMAP) is a measurement obtained through EMG testing that is associated with disease progression. In this study, we measure the maximum CMAP by stimulating one nerve in the hand and measuring the response of the muscle. This is done multiple times, the outcome used is the highest peak, or response observed. (NCT00227266)
Timeframe: 1 month prior to official enrollment, beginning of study (0 months), 6 months, 12 months (data point not available)
| Intervention | mV (Mean) | |
|---|---|---|
| Baseline | 6 months | |
| Cohort 1a Sitters Placebo Then Treatment | 2.28 | 2.32 |
| Cohort 1b Sitters Treatment | 2.93 | 2.37 |
| Cohort 2 Standers and Walkers - Treatment | 5.52 | 6.56 |
The maximum Compound Motor Action Potential (CMAP) is a measurement obtained through EMG testing that is associated with disease progression. In this study, we measure the maximum CMAP by stimulating one nerve in the hand and measuring the response of the muscle. This is done multiple times, the outcome used is the highest peak, or response observed. (NCT00227266)
Timeframe: 1 month prior to official enrollment, beginning of study (0 months), 6 months, 12 months (data point not available)
| Intervention | mV (Median) | |
|---|---|---|
| Baseline | 6 months | |
| Cohort 1a Sitters Placebo Then Treatment | 1.91 | 1.44 |
| Cohort 1b Sitters Treatment | 2.2 | 1.8 |
| Cohort 2 Standers and Walkers - Treatment | 5.3 | 5.85 |
The maximum Compound Motor Action Potential (CMAP) area is a measurement obtained through EMG testing that is associated with disease progression. In this study, we measure the maximum CMAP by stimulating one nerve in the hand and measuring the response of the muscle. This procedure is repeated multiple times. The maximum area is the response that results in the largest area under the response curve. (NCT00227266)
Timeframe: 1 month prior to official enrollment, beginning of study (0 months), 6 months, 12 months (data point not available)
| Intervention | mVms (Mean) | |
|---|---|---|
| Baseline | 6 months | |
| Cohort 1a Sitters Placebo Then Treatment | 5.46 | 5.28 |
| Cohort 1b Sitters Treatment | 5.45 | 5.26 |
| Cohort 2 Standers and Walkers - Treatment | 14.85 | 16.26 |
The maximum Compound Motor Action Potential (CMAP) area is a measurement obtained through EMG testing that is associated with disease progression. In this study, we measure the maximum CMAP by stimulating one nerve in the hand and measuring the response of the muscle. This procedure is repeated multiple times. The maximum area is the response that results in the largest area under the response curve. (NCT00227266)
Timeframe: 1 month prior to official enrollment, beginning of study (0 months), 6 months, 12 months (data point not available)
| Intervention | mVms (Median) | |
|---|---|---|
| Baseline | 6 months | |
| Cohort 1a Sitters Placebo Then Treatment | 3.6 | 3.74 |
| Cohort 1b Sitters Treatment | 4.6 | 3.4 |
| Cohort 2 Standers and Walkers - Treatment | 13.65 | 16.85 |
Comparison of Modified Hammersmith Change from baseline to 6 months. Scores range from 0 to 40. A higher score indicates a better outcome. This scale is used to assess gross motor abilities of non-ambulant children with SMA in multiple research trials as well as in clinical settings. (NCT00227266)
Timeframe: 0 months, 6 months
| Intervention | Score (Mean) | ||
|---|---|---|---|
| Baseline visit (0 weeks) | 6 Month visit (V2) | Change from Baseline | |
| Cohort 1a Sitters Placebo Then Treatment | 20.0 | 20.6 | 0.6 |
| Cohort 1b Sitters Treatment | 16.6 | 16.8 | 0.2 |
"Baseline Modified Hammersmith Extend testing. The baseline test is the score they receive during their screening visits. This scale ranges from 0 to 56. A higher score indicates a better outcome.~This scale is used to assess gross motor abilities of children with SMA in multiple research trials as well as in clinical settings." (NCT00227266)
Timeframe: 1 month prior to enrollment, at enrollment (0 months)
| Intervention | Score (Mean) | |
|---|---|---|
| Modified Hammersmith Extend at S1 (-4 weeks) | Modified Hammersmith Extend at S2 (0 weeks) | |
| Cohort 2 Experimental | 47.0 | 48.3 |
3 reviews available for carnitine and Acetonemia
| Article | Year |
|---|---|
Disturbed bovine mitochondrial lipid metabolism: a review.
Topics: Acyl-CoA Dehydrogenases; Animals; Carnitine; Cattle; Cattle Diseases; Fatty Acids; Female; Ketosis; | 2017 |
Metabolic and endocrine aspects of the ketogenic diet.
Topics: 3-Hydroxybutyric Acid; Anticonvulsants; Carnitine; Dietary Fats; Energy Metabolism; Epilepsy; Fatty | 1999 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
Carnitine metabolism and function in humans.
Topics: Absorption; Acidosis; Adolescent; Adult; Aged; Animals; Biological Transport; Cardiomyopathies; Carn | 1986 |
4 trials available for carnitine and Acetonemia
| Article | Year |
|---|---|
Nutritional ketosis improves exercise metabolism in patients with very long-chain acyl-CoA dehydrogenase deficiency.
Topics: Adolescent; Adult; Beverages; Blood Glucose; Carnitine; Congenital Bone Marrow Failure Syndromes; Cr | 2020 |
Effect of two treatment protocols for ketosis on the resolution, postpartum health, milk yield, and reproductive outcomes of dairy cows.
Topics: 3-Hydroxybutyric Acid; Animals; Carnitine; Cattle; Cattle Diseases; Female; Haptoglobins; Ketosis; L | 2018 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.
Topics: Adiposity; Athletes; Carbohydrates; Carnitine; Diet; Energy Metabolism; Exercise; Female; Glycogen; | 2016 |
Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Carnitine; Child; Child, Preschool; Dietary Fats; | 2006 |
26 other studies available for carnitine and Acetonemia
| Article | Year |
|---|---|
Altered Serum Amino Acid and Acylcarnitine Profiles in Hyperinsulinemic Hypoglycemia and Ketotic Hypoglycemia.
Topics: Amino Acids; Biomarkers; Carnitine; Case-Control Studies; Child, Preschool; Congenital Hyperinsulini | 2020 |
Alterations in Hepatic FGF21, Co-Regulated Genes, and Upstream Metabolic Genes in Response to Nutrition, Ketosis and Inflammation in Peripartal Holstein Cows.
Topics: Angiopoietins; Animal Nutritional Physiological Phenomena; Animals; Carnitine; Cattle; Circadian Rhy | 2015 |
Beta-ketothiolase deficiency brought with lethargy: case report.
Topics: 3-Hydroxybutyric Acid; Acetyl-CoA C-Acyltransferase; Amino Acid Metabolism, Inborn Errors; Carnitine | 2011 |
Characterization of D-3-hydroxybutyrylcarnitine (ketocarnitine): an identified ketosis-induced metabolite.
Topics: Adolescent; Adult; Carnitine; Coenzyme A Ligases; Fasting; Fatty Acids; Humans; Ketone Bodies; Ketos | 2012 |
Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activity.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Butyrates; Carnitine; Carnitine O-Palmitoyltransferas | 2003 |
Glucose and leucine kinetics in idiopathic ketotic hypoglycaemia.
Topics: Alanine; Amino Acids, Branched-Chain; Basal Metabolism; Calorimetry, Indirect; Carnitine; Case-Contr | 2006 |
Mechanism of training-induced attenuation of postexercise ketosis.
Topics: 3-Hydroxybutyric Acid; Acidosis; Animals; Carnitine; Cyclic AMP; Hydroxybutyrates; Ketosis; Liver; L | 1984 |
Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels.
Topics: Acyl-CoA Dehydrogenase, Long-Chain; Carnitine; Child; Child, Preschool; Fasting; Fatty Acids; Fatty | 1983 |
Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis.
Topics: Acetylcarnitine; Acidosis; Adolescent; Adult; Aged; Body Weight; Carnitine; Child; Diabetic Ketoacid | 1982 |
Carnitine and carnitine palmitoyltransferase in fatty acid oxidation and ketosis.
Topics: Acidosis; Acyltransferases; Animals; Carnitine; Carnitine Acyltransferases; Carnitine O-Palmitoyltra | 1982 |
Neonatal onset of medium-chain acyl-coenzyme A dehydrogenase deficiency with confusing biochemical features.
Topics: Acyl-CoA Dehydrogenase; Blood Glucose; Carnitine; Fatty Acid Desaturases; Fatty Acids; Female; Human | 1995 |
Congenital lacticacidemia caused by lipoamide dehydrogenase deficiency with favorable outcome.
Topics: Acidosis, Lactic; Carnitine; Dichloroacetic Acid; Dihydrolipoamide Dehydrogenase; Fibroblasts; Human | 1995 |
Complications of the ketogenic diet.
Topics: Adolescent; Carnitine; Child; Child, Preschool; Combined Modality Therapy; Epilepsy; Follow-Up Studi | 1998 |
Long-chain hydroxydicarboxylic aciduria, carnitine depletion and acetaminophen exposure.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Acetaminophen; Analgesics, Non-Narcotic; Carnitine; Fatty Acids; H | 2000 |
Dietary L-carnitine supplementation in obese cats alters carnitine metabolism and decreases ketosis during fasting and induced hepatic lipidosis.
Topics: 3-Hydroxybutyric Acid; Animals; Carnitine; Cat Diseases; Cats; Dietary Supplements; Fasting; Fatty A | 2002 |
Carnitine levels and the ketogenic diet.
Topics: Adolescent; Adult; Carnitine; Child; Child, Preschool; Dietary Carbohydrates; Dietary Fats; Epilepsy | 2001 |
Hormonal control of ketogenesis. Biochemical considerations.
Topics: Acetoacetates; Acidosis; Adipose Tissue; Alcoholism; Animals; Carnitine; Carnitine Acyltransferases; | 1977 |
Maternal-fetal carnitine relationship and neonatal ketosis in the rat.
Topics: Acidosis; Aging; Animals; Animals, Newborn; Body Weight; Carnitine; Fasting; Female; Fetus; Ketone B | 1976 |
Glucagon and ketogenesis.
Topics: Acidosis; Age Factors; Animals; Animals, Newborn; Carnitine; Female; Glucagon; Ketone Bodies; Ketosi | 1976 |
Sodium pivalate treatment reduces tissue carnitines and enhances ketosis in rats.
Topics: Animals; Carnitine; Chromatography, High Pressure Liquid; Ketosis; Liver; Male; Pentanoic Acids; Rat | 1991 |
Valproate-induced coma with ketosis and carnitine insufficiency.
Topics: Acids; Adult; Carnitine; Coma; Epilepsies, Partial; Epilepsy, Temporal Lobe; Female; Humans; Ketosis | 1990 |
Attenuation of postexercise ketosis in fasted endurance-trained rats.
Topics: 3-Hydroxybutyric Acid; Acidosis; Adaptation, Physiological; Animals; Carnitine; Cyclic AMP; Fasting; | 1985 |
Ketosis, serum carnitine and its precursor amino acids in normal and diabetic ethiopians.
Topics: Acidosis; Adolescent; Adult; Amino Acids; Carnitine; Diabetes Mellitus, Type 1; Diabetic Ketoacidosi | 1987 |
The effects of post-exercise glucose and alanine ingestion on plasma carnitine and ketosis in humans.
Topics: 3-Hydroxybutyric Acid; Acidosis; Adult; Alanine; Carnitine; Fasting; Fatty Acids, Nonesterified; Glu | 1987 |
Interrelationships between milk carnitine and blood and milk components and tissue carnitine in normal and ketotic cows.
Topics: Acetoacetates; Acidosis; Animals; Blood Glucose; Brain; Carnitine; Cattle; Cattle Diseases; Fatty Ac | 1974 |
On the mechanism of ketogenesis and its control. I. On a possible role of acetoacetyl-CoA thiolase in the control of ketone body production.
Topics: Acetates; Acetoacetates; Acetyltransferases; Acute Disease; Animals; Aspartic Acid; Carbon Radioisot | 1973 |